Want to see JP:7779 full AI Analyst Report?
Top Page
CYBERDYNE
(7779)
Select Model
Select Model
Rating:49Neutral
Price Target:
¥210.00
▼(-9.09% Downside)
Action:Reiterated
Date:08/19/26
The score is held back primarily by weak cash flow (negative TTM operating and free cash flow) and a very expensive valuation (P/E ~185). These risks are partially offset by strong recent revenue growth and a very low-leverage balance sheet that provides financial flexibility. Technicals are mixed, with only modest near-term improvement against a weaker longer-term trend.
Positive Factors
Strong TTM revenue growth
A 70.2% increase in trailing revenue indicates meaningful expansion in customer deployments or related technology activity. If sustained, this growth can improve operating leverage, broaden market adoption of HAL and strengthen the company’s ability to fund product development.
Negative Factors
Negative operating and free cash flow
Current cash burn means reported growth is not yet translating into internally generated funds. Persistently negative operating and free cash flow could increase reliance on the balance sheet, restrict investment flexibility and make the company more vulnerable if commercialization takes longer than expected.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong TTM revenue growth
A 70.2% increase in trailing revenue indicates meaningful expansion in customer deployments or related technology activity. If sustained, this growth can improve operating leverage, broaden market adoption of HAL and strengthen the company’s ability to fund product development.
Read all positive factors
CYBERDYNE (7779) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥44.55B
Dividend YieldN/A
Average Volume (3M)877.67K
Price to Earnings (P/E)162.3
Beta (1Y)0.99
Revenue Growth-8.42%
EPS GrowthN/A
CountryJP
Employees203
SectorHealthcare
Sector Strength45
IndustryMedical - Devices
Share Statistics
EPS (TTM)1.30
Shares Outstanding137,445,820
10 Day Avg. Volume806,320
30 Day Avg. Volume877,666
Financial Highlights & Ratios
PEG Ratio-2.89
Price to Book (P/B)1.40
Price to Sales (P/S)14.44
P/FCF Ratio305.10
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
¥380.00Price Target Upside64.50% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)4.1
Revenue Forecast (FY)¥4.87B
CYBERDYNE Business Overview & Revenue Model
Company Description
Headquartered in Tsukuba, Japan, and founded in 2004, CYBERDYNE Inc. is dedicated to the ongoing research, development, production, sales, leasing, and maintenance of sophisticated equipment and systems, primarily for the medical and defense secto...
How the Company Makes Money
CYBERDYNE makes money primarily by commercializing its robotic assistive technologies—most notably the HAL exoskeleton—through providing the product and associated usage arrangements to healthcare and care-related customers. Revenue is generated f...
CYBERDYNE Financial Statement Overview
Summary
Income Statement
46
Neutral
Balance Sheet
83
Very Positive
Cash Flow
38
Negative
| Breakdown | TTM | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 3.87B | 3.85B | 4.38B | 4.35B | 3.29B | 2.15B |
| Gross Profit | 1.92B | 2.27B | 2.07B | 2.03B | 1.49B | 1.25B |
| EBITDA | -424.00M | -489.00M | -904.00M | -1.06B | -722.00M | -565.00M |
| Net Income | 276.00M | 153.00M | -577.00M | -1.48B | -298.00M | -498.00M |
Balance Sheet | ||||||
| Total Assets | 49.74B | 49.08B | 48.55B | 50.00B | 50.19B | 49.47B |
| Cash, Cash Equivalents and Short-Term Investments | 13.12B | 8.99B | 6.82B | 5.16B | 7.80B | 20.83B |
| Total Debt | 540.00M | 467.00M | 434.00M | 632.00M | 669.00M | 575.00M |
| Total Liabilities | 9.65B | 9.47B | 8.95B | 9.52B | 8.20B | 6.02B |
| Stockholders Equity | 40.09B | 39.62B | 39.58B | 40.75B | 42.10B | 43.41B |
Cash Flow | ||||||
| Free Cash Flow | -117.00M | 182.00M | -726.00M | -1.07B | -594.00M | -2.33B |
| Operating Cash Flow | -108.00M | 195.00M | -430.00M | -850.00M | -143.00M | -564.00M |
| Investing Cash Flow | 8.20B | 2.09B | 2.33B | -2.08B | 2.17B | -1.79B |
| Financing Cash Flow | -216.00M | -205.00M | -216.00M | 160.00M | 14.00M | 1.25B |
CYBERDYNE Technical Analysis
Negative
231.00
Price Trends
228.90
Negative
243.95
Negative
261.77
Negative
Market Momentum
-3.95
Positive
34.13
Neutral
8.87
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7779, the sentiment is Negative. The current price of 231 is above the 20-day moving average (MA) of 227.60, above the 50-day MA of 228.90, and below the 200-day MA of 261.77, indicating a bearish trend. The MACD of -3.95 indicates Positive momentum. The RSI at 34.13 is Neutral, neither overbought nor oversold. The STOCH value of 8.87 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:7779.
CYBERDYNE Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | ¥10.30B | 16.76 | ― | 4.24% | 5.20% | -17.92% | |
64 Neutral | ¥201.94B | 21.89 | 5.76% | 2.65% | 3.04% | -19.26% | |
64 Neutral | ¥9.04B | 10.75 | ― | 2.72% | 9.02% | 8.88% | |
63 Neutral | ¥269.36B | 19.63 | ― | 1.95% | 1.43% | 1.86% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
49 Neutral | ¥44.55B | 162.31 | 0.69% | ― | -8.42% | ― | |
47 Neutral | ¥16.12B | -73.12 | ― | 2.78% | -6.64% | 67.08% |
* Healthcare Sector Average
JP:7779
CYBERDYNE
211.00
22.00
11.64%
JP:6523
PHC Holdings Corp.
1,586.00
586.66
58.71%
JP:5187
Create Medic Co., Ltd.
1,132.00
173.37
18.09%
JP:6849
Nihon Kohden Corporation
1,643.00
-124.94
-7.07%
JP:7600
Japan Medical Dynamic Marketing, Inc.
612.00
118.92
24.12%
JP:7963
Koken Ltd.
1,839.00
151.33
8.97%
CYBERDYNE Corporate Events
CYBERDYNE Posts Higher Q1 Profit but Withholds Full-Year Forecast Amid Market Uncertainty
Aug 13, 2026
CYBERDYNE, Inc. reported consolidated revenue of ¥1,027 million for the three months ended June 30, 2026, a 2.7% year-on-year increase, with profit attributable to owners of the parent rising 49.2% to ¥374 million and basic earnings per ...
CYBERDYNE Boosts SIP Smart Mobility Consignment to ¥194 Million
Jul 29, 2026
CYBERDYNE Inc., a Japanese technology firm listed on the Tokyo Stock Exchange’s Growth Section, specializes in advanced systems and robotics and is an active participant in public-sector innovation projects. Its engagement in national smart ...
CYBERDYNE Boosts SIP Consignment Budget for Human Collaborative Robotics Project
Jul 28, 2026
CYBERDYNE Inc. has revised its business consignment agreement under Japan’s Cross-ministerial Strategic Innovation Promotion Program’s third phase, which targets the development and social implementation of human collaborative robotics...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.